TBL1XR1 and nasopharyngeal carcinoma: In addition, in vitro assays indicated that TBL1XR1 promoted anti-apoptosis in NPC cells by activating NF-κB pathway, further cementing the role of TBL1XR1 as an oncogenic protein [14, 15].